Pugliano C, Berger M, Ray R, Sapkos K, Wu B, Laird A
Mol Ther Methods Clin Dev. 2025; 32(3):101297.
PMID: 40012884
PMC: 11863497.
DOI: 10.1016/j.omtm.2024.101297.
Itkin T, Houghton S, Schreiner R, Lin Y, Badwe C, Voisin V
Nat Immunol. 2025; 26(3):378-390.
PMID: 40000903
DOI: 10.1038/s41590-025-02087-w.
Mo Y, Fan D, Wang W, Wang S, Yan Y, Zhao Z
Discov Oncol. 2025; 16(1):154.
PMID: 39932605
PMC: 11813837.
DOI: 10.1007/s12672-025-01894-9.
Wu X, Wei J, Ran W, Liu D, Yi Y, Gong M
Adv Sci (Weinh). 2025; 12(10):e2412234.
PMID: 39836604
PMC: 11904984.
DOI: 10.1002/advs.202412234.
Wu L, Li X, Li J, Wang Y, Yang C, Zhao C
Front Immunol. 2024; 15:1494570.
PMID: 39575260
PMC: 11580016.
DOI: 10.3389/fimmu.2024.1494570.
Unveiling the Immune effects of AHR in tumors: a decade of insights from bibliometric analysis (2010-2023).
Xie A, Wang T, Shi W, He F, Sun X, Li P
Discov Oncol. 2024; 15(1):616.
PMID: 39495340
PMC: 11535112.
DOI: 10.1007/s12672-024-01480-5.
Long-term exposure to BAY2416964 reduces proliferation, migration and recapitulates transcriptional changes induced by AHR loss in PyMT-induced mammary tumor cells.
Olafsen N, Das S, Gorrini C, Matthews J
Front Oncol. 2024; 14:1466658.
PMID: 39450255
PMC: 11499230.
DOI: 10.3389/fonc.2024.1466658.
and expansion of CD33/HBG promoter-edited HSPCs with Mylotarg.
Georgakopoulou A, Li C, Kiem H, Lieber A
Mol Ther Methods Clin Dev. 2024; 32(4):101343.
PMID: 39429723
PMC: 11490927.
DOI: 10.1016/j.omtm.2024.101343.
Endocytosis as a critical regulator of hematopoietic stem cell fate -implications for hematopoietic stem cell and gene therapy.
Chandraprabha P, Thangavel S
Stem Cell Res Ther. 2024; 15(1):319.
PMID: 39334274
PMC: 11438103.
DOI: 10.1186/s13287-024-03927-6.
Extensive immunophenotypic sub-population analysis of StemRegenin1 expanded haematopoietic stem/progenitor cells.
Mellet J, Hendricks C, Stivaktas V, Durandt C, Ambele M, Pepper M
Stem Cell Res Ther. 2024; 15(1):317.
PMID: 39304924
PMC: 11416017.
DOI: 10.1186/s13287-024-03895-x.
UM171 enhances fitness and engraftment of gene-modified hematopoietic stem cells from patients with sickle cell disease.
Liu B, Klatt D, Zhou Y, Manis J, Sauvageau G, Pellin D
Blood Adv. 2024; 8(22):5885-5895.
PMID: 39293082
PMC: 11612367.
DOI: 10.1182/bloodadvances.2024013932.
Discovery and optimisation of pyrazolo[1,5-]pyrimidines as aryl hydrocarbon receptor antagonists.
Bobrovs R, Terentjeva S, Olafsen N, Dambrauskas Z, Gulbinas A, Maimets T
RSC Med Chem. 2024; .
PMID: 39246744
PMC: 11376203.
DOI: 10.1039/d4md00266k.
The influence of AHR on immune and tissue biology.
Stockinger B, Diaz O, Wincent E
EMBO Mol Med. 2024; 16(10):2290-2298.
PMID: 39242971
PMC: 11473696.
DOI: 10.1038/s44321-024-00135-w.
CD9 and Aryl Hydrocarbon Receptor Are Markers of Human CD19+CD14+ Atypical B Cells and Are Dysregulated in Systemic Lupus Erythematous Disease.
Blevins L, Khan D, Crawford R, ONeill C, Bach A, Zhou J
J Immunol. 2024; 213(8):1076-1092.
PMID: 39212542
PMC: 11458359.
DOI: 10.4049/jimmunol.2400193.
Aryl hydrocarbon receptor: current perspectives on key signaling partners and immunoregulatory role in inflammatory diseases.
Bahman F, Choudhry K, Al-Rashed F, Al-Mulla F, Sindhu S, Ahmad R
Front Immunol. 2024; 15:1421346.
PMID: 39211042
PMC: 11358079.
DOI: 10.3389/fimmu.2024.1421346.
Synthesis at the Interface of Chemistry and Biology.
Schultz P
Acc Chem Res. 2024; 57(18):2631-2642.
PMID: 39198974
PMC: 11443489.
DOI: 10.1021/acs.accounts.4c00320.
Umbilical cord blood derived cell expansion: a potential neuroprotective therapy.
Penny T, Jenkin G, Miller S, McDonald C
Stem Cell Res Ther. 2024; 15(1):234.
PMID: 39075614
PMC: 11287950.
DOI: 10.1186/s13287-024-03830-0.
Utilizing epigenetic regulators to improve HSC-based lentiviral gene therapy.
Tajer P, Karakaslar E, Cante-Barrett K, Naber B, Vloemans S, van Eggermond M
Blood Adv. 2024; 8(18):4936-4947.
PMID: 38916861
PMC: 11421325.
DOI: 10.1182/bloodadvances.2024013047.
Engineering an inducible leukemia-associated fusion protein enables large-scale ex vivo production of functional human phagocytes.
Windisch R, Soliman S, Hoffmann A, Chen-Wichmann L, Danese A, Vosberg S
Proc Natl Acad Sci U S A. 2024; 121(25):e2312499121.
PMID: 38857395
PMC: 11194515.
DOI: 10.1073/pnas.2312499121.
Advances in ex vivo expansion of hematopoietic stem and progenitor cells for clinical applications.
Branco A, Rayabaram J, Miranda C, Fernandes-Platzgummer A, Fernandes T, Sajja S
Front Bioeng Biotechnol. 2024; 12:1380950.
PMID: 38846805
PMC: 11153805.
DOI: 10.3389/fbioe.2024.1380950.